Skip to main content
Midas Edge

InspireMD, Inc.

For the period ended Mar 31, 2026. Filed May 7, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 7, 2026

NSPR$0.71+2.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Condensed Consolidated Statements of Changes in Equity

(U.S. dollars in thousands, except share data)

Common stock · Preferred C shares · Additional paid-in · Accumulated · Total
SharesAmountSharesAmountcapitaldeficitequity
BALANCE AT January 1, 202526,611,03331,718-*289,589(253,506)36,086
Net loss(11,166)(11,166)
Exercise of pre-funded warrants643,860-*-----*
Issuance of common stock, included at the market offering net of $22 issuance costs273,621-*--696-696
Share-based compensation related to restricted stock, restricted stock units and stock options award, net of forfeitures of 29,295 shares2,224,147-*--2,729-2,729
BALANCE AT March 31, 202529,752,66131,718-*293,014(264,672)28,345
*Represents an amount less than $1 thousand

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

(U.S. dollars in thousands, except share data)

Common stock · Preferred C shares · Additional paid-in · Accumulated · Total
SharesAmountSharesAmountcapitaldeficitequity
BALANCE AT January 1, 202643,532,28141,718-*357,489(302,292)55,201
Net loss-(13,689)(13,689)
Share-based compensation related to restricted stock, restricted stock units and stock options award, net of forfeitures of 276,373 shares3,306,682-*-2,105-2,105
BALANCE AT March 31, 202646,838,96341,718-*359,594(315,981)43,617
*Represents an amount less than $1 thousand
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.